Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds
Tau is a microtubule-associated protein essential for microtubule assembly and stability in neurons. The abnormal intracellular accumulation of tau aggregates is a major characteristic of brains from patients with Alzheimer’s disease (AD) and other tauopathies. In AD, the presence of neurofibrillary...
Main Authors: | Huahua Shi, Yan Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/2/831 |
Similar Items
-
Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01) -
PET Imaging of Tau Pathology: Towards an affirmative diagnosis of Alzheimer’s and Tauopathies
by: Olga eJames, et al.
Published: (2015-03-01) -
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
by: Moxin Wu, et al.
Published: (2021-11-01) -
Alzheimer’s disease brain contains tau fractions with differential prion-like activities
by: Longfei Li, et al.
Published: (2021-02-01) -
Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis
by: Wen Hu, et al.
Published: (2017-09-01)